Depatuxizumab MMAF

EGFR

Tyrosine Kinase/Adaptors|||Angiogenesis|||JAK/STAT signaling

Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized in glioblastoma research.

Cool pack

-20°C

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-22307IR 0.1 mL

Ask

ABF2016 100 µg

Ask

MBS2607336-01 48 Well

Ask

MBS2607336-02 96 Well

Ask

MBS2607336-03 5x 96 Well

Ask

MBS2607336-04 10x 96 Well

Ask